companies fresenius-kabi-ag 
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. FYB201/BQ201/CHS-201 (Formycon AG / Bioeq AG / Coherus).
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 7, 2022
Reynolds Vapor Company v. Spectrum Solutions LLC, JSR Corporation, and Fresenius Kabi USA LLC. In Adidas AG v. Citing Sotera in its analysis of Fintiv factor 4, the Board found that the stipulation “address[ed] any concerns about overlap between the issues presented in the two fora” and instituted IPR. Similarly, in R.J.
Expert insights. Personalized for you.
52 
Let's personalize your content